About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 41,977 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 41,977 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 41,977 trials

Not yet recruitingXenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac ArrestXePOHCAS: Prospective, randomized, multicenter interventional trial in adult subjects with out-of-hospital cardiac arrest comparing treatment with standard-of-care post-cardiac…NCT03176186·Hartford, Connecticut and 9 others CompletedA Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.This study will determine the maximum tolerated dose of RO5045337 and the optimal associated 4 weekly dosing schedule of RO5045337, administered as monotherapy in patients with…NCT00623870·Duarte, California and 10 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedA Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster VaccineThe aim of this study was to evaluate the immune response and safety of both GlaxoSmithKline Biologicals SA's (GSK's) herpes zoster (HZ) subunit (su) vaccine in healthy adults 50…NCT05047770·Tempe, Arizona and 45 others

CompletedErlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid TumorsRATIONALE: Erlotinib may interfere with the growth of tumor cells and slow the growth of the tumor.NCT00033241·Tucson, Arizona and 1 other

CompletedA Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and AdultsThe purpose of this study was to assess the safety, effectiveness, and immune response of the meningococcal combined ABCWY vaccine (GSK4023393A) intended to protect against…NCT04886154·Colorado Springs, Colorado and 52 others

TerminatedPhase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung CancersEvaluate safety and tolerability, while establishing the recommended dose of the investigational drug combination of adagrasib and olaparib that can be given to participants with…NCT06130254·Houston, Texas

CompletedSimufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsA two-year safety study of simufilam (PTI-125) 100 mg oral tablets twice daily for participants of the previous simufilam studies as wells as additional new mild-to-moderate…NCT04388254·Gilbert, Arizona and 16 others

CompletedPRospective Study Of MammaPrint in Patients With an Intermediate Recurrence ScoreThis is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype…NCT01617954·Phoenix, Arizona and 52 others

RecruitingWISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)NCT06967805·Birmingham, Alabama and 70 others

TerminatedStudy of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCTThis is a Phase 1, open-label, non-randomized, single and multiple dose escalation study designed to evaluate the safety and preliminary efficacy of administering Mana 312 to…NCT04679194·Denver, Colorado and 7 others

TerminatedStudy of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)The objective of this trial is to study REGN4659 and cemiplimab in treatment-experienced, non-small cell lung cancer (NSCLC) patients.NCT03580694·Chicago, Illinois and 5 others

TerminatedSafety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)The purpose of the study is to evaluate the long-term safety and tolerability of SHP465 at 6.25 milligram (mg) in children aged 4 to 12 years diagnosed with…NCT03325894·Dothan, Alabama and 47 others

TerminatedSafety and Preliminary Efficacy Study of V404 PDS in UveitisThis study is intended to evaluate the safety of V404 PDS in patients with chronic non-infectious uveitis.NCT02125266·Golden, Colorado and 4 others

Active not recruitingStudy of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular LymphomaFollicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes.NCT05409066·Tucson, Arizona and 272 others

AvailableCompassionate Use of Concizumab if You Have HaemophiliaThe compassionate use programme will give participants concizumab for free, even though it is not yet approved by health authorities.NCT04921956·Los Angeles, California and 24 others

CompletedA Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesThis is a Phase 1, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity of…NCT03629756·Scottsdale, Arizona and 14 others

CompletedAllogeneic Transplantation in Patients With Cutaneous T-Cell LymphomaThe goal of this clinical research study is to see if receiving a transplant of blood stem cells (cells that can produce blood) or bone marrow from either a related donor…NCT00506129·Houston, Texas

CompletedA Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionThe objectives of this study are to assess the pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir adult formulation in adolescents ages 12 to 17 years and a…NCT03067129·San Francisco, California and 37 others

Not yet recruitingPovidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-center Stepped Wedge Cluster Randomized StudyThe purpose of this study is to determine the effect of intra-abdominal irrigation with povidone-iodine (PVI) versus usual care on the rate of 30-day postoperative intra-abdominal…NCT04200729·Houston, Texas

RecruitingMilk And Growth In Children (MAGIC) Born Very Preterm: A Randomized TrialThe goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition…NCT06420531·Birmingham, Alabama and 3 others

PreviousPage 6 of 2099Next

Heart Diseasein Texas